BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection

[at noodls] – Broad Spectrum Activity Shown Against Multiple RNA Virus Biothreats RESEARCH TRIANGLE PARK, N.C., March 3, 2014 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced the online … more

View todays social media effects on BCRX

View the latest stocks trending across Twitter. Click to view dashboard

See who BioCryst is hiring next, click here to view